Clinical trials
Phase 2/3 Asthma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2004 | 2 |
| 2005 | 4 |
| 2006 | 7 |
| 2008 | 1 |
| 2009 | 4 |
| 2010 | 5 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 3 |
| 2017 | 3 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 32 |
| Unknown status | 8 |
| Withdrawn | 4 |
| Active, not recruiting | 2 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2 |
| McMaster University | 2 |
| Milton S. Hershey Medical Center | 2 |
| Post Graduate Institute of Medical Education and Research, Chandigarh | 2 |
| University of Glasgow | 2 |
| University of Utah | 2 |
| Vectura Limited | 2 |
| ALK-Abelló A/S | 1 |
| AstraZeneca | 1 |
| Barts & The London NHS Trust | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Asthma | 48 |
| Hypersensitivity | 3 |
| Aspergillosis, Allergic Bronchopulmonary | 2 |
| Inflammation | 2 |
| Lung Diseases, Obstructive | 2 |
| Pulmonary Disease, Chronic Obstructive | 2 |
| Status Asthmaticus | 2 |
| Bronchial Spasm | 1 |
| Bronchitis | 1 |
| Cardiovascular Diseases | 1 |
Trials
Showing 26 to 48 of 48. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.